Erica D. Pratt, Ph.D.
Affiliations: | 2008-2015 | Biomedical Engineering | Cornell University, Ithaca, NY, United States |
Area:
liquid biopsy, noninvasive cancer assays, microfluidics, dPCR, post-translational modifications, peptide engineeringGoogle:
"Erica D. Pratt"Mean distance: (not calculated yet)
Parents
Sign in to add mentorBrian J. Kirby | grad student | 2008-2015 | Cornell |
Laurie L. Parker | post-doc | 2018-2021 | UMN |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Widstrom NE, Perez M, Pratt ED, et al. (2022) Novel Bruton's Tyrosine Kinase (BTK) Substrates for Time-Resolved Luminescence Assays. Acs Chemical Biology. 17: 1328-1333 |
Jena S, Damayanti NP, Tan J, et al. (2020) Multiplexable fluorescence lifetime imaging (FLIM) probes for Abl and Src-family kinases. Chemical Communications (Cambridge, England) |
Antonarakis ES, Tagawa ST, Galletti G, et al. (2017) Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017724138 |
Tagawa ST, Galletti G, Antonarakis ES, et al. (2015) Baseline analysis of circulating tumor cell (CTC) enumeration and androgen receptor (AR) localization in men with metastatic castration-resistant prostate cancer (mCRPC) in TAXYNERGY. Journal of Clinical Oncology. 33: 5031-5031 |
Tagawa S, Galletti G, Antonarakis E, et al. (2015) 2563 Screening and baseline analysis of circulating tumor cell (CTC) counts and androgen receptor (AR) localization with clinical characteristics of men with metastatic castration-resistant prostate cancer (mCRPC) in TAXYNERGY European Journal of Cancer. 51: S498-S499 |
Pratt ED, Stepansky A, Hicks J, et al. (2014) Single-cell copy number analysis of prostate cancer cells captured with geometrically enhanced differential immunocapture microdevices. Analytical Chemistry. 86: 11013-7 |
Kirby BJ, Jodari M, Loftus MS, et al. (2012) Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device. Plos One. 7: e35976 |
Kirby BJ, Jodari M, Loftus MS, et al. (2012) Correction: Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic Device Plos One. 7 |
Jodari M, Loftus M, Gleghorn J, et al. (2011) Capture and analysis of prostate cancer circulating tumor cells (CTCS) using geometrically enhanced differential immunocapture (GEDI). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 53 |
Pratt ED, Huang C, Hawkins BG, et al. (2011) Rare Cell Capture in Microfluidic Devices. Chemical Engineering Science. 66: 1508-1522 |